David Liu Wins 2025 Breakthrough Prize for Revolutionary Gene-Editing Platform

David Liu was awarded the prestigious 2025 Breakthrough Prize in Life Sciences for his pioneering work on a revolutionary gene-editing platform that can precisely correct genetic mutations.

This platform has already entered clinical trials for conditions including sickle cell disease, high cholesterol, and certain cancers. "The ability to correct genetic mutations precisely opens the door to treating thousands of inherited diseases," Liu said.